Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment.. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light nighttime sleep of residents.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Light-therapy in Alzheimer's Disease

NCT02686190

Alzheimer's Disease

COMPLETED NA

Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's

NCT02502045

Alzheimer's Disease

COMPLETED NA

Therapy Light Rooms for Improved Sleep in Dementia Patients

NCT03357328

Sleep Fragmentation Behavioural and Psychiatric Symptoms of Dementia Dementia

COMPLETED NA

Lighting for Older Adults With Dementia

NCT05697757

Sleep Mood

COMPLETED NA

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

NCT05837819

Alzheimer's Disease Sleep Disturbance

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment. In 2014, the Cochrane published a systematic review of the literature over the last 20 years concerning the use of light therapy in patients with a AD. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light therapy (from 5 a.m to 10 p.m) on nighttime sleep of residents. Secondary objectives were the study of sleep time on the day, anxiety by the COVI scale and behavioral disorders by the NPI scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polypathology and Autonomy Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Light therapy

Innovative ambient lighting

Group Type OTHER

Light therapy

Intervention Type DEVICE

14-days exposure with an innovative ambient light

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Light therapy

14-days exposure with an innovative ambient light

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* EHPAD residents at Les Pastoureaux Valenton having moderate to severe MASA
* More than 60 years
* Presenting motor behavioral disorders and / or anxiety and / or restlessness and / or insomnia .
* No underlying acute medical problems including no delirium

* total acquired or congenital blindness
* bedridden patient ( loss of physical autonomy)
* Entry to the residence less than 15 days before the start of the experiment.